Genome-wide screening for genetic alterations in Esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Ying, Jianming ^a,b   Shan, Ling ^a   Li, Jisheng ^b,c   Zhong, Lan ^b   Xue, Liyan ^a   Zhao, Hong ^a   Li, Lili ^b   Langford, Cordelia ^d   Guo, Lei ^a   Qiu, Tian ^a   Lu, Ning ^a   Tao, Qian ^b  

^a CANCER HOSPITAL   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHANDONG UNIVERSITY   (China)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CCND1 GENE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 18P; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 8P; CHROMOSOME GAIN; CHROMOSOME LOSS; CHROMOSOMES AND CHROMOSOMAL PHENOMENA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FGF19 GENE; GENE AMPLIFICATION; GENE DELETION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC IDENTIFICATION; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; ONCOGENE; PATHOGENESIS; SHANK2 GENE;

BETA CATENIN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; ESOPHAGEAL NEOPLASMS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; ONCOGENES; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 84862654141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039797     Document Type: Article

References (45)

1. Parkin DM, Pisani P, Ferlay J, (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 19: 594-606.
2. Pera M, Manterola C, Vidal O, Grande L, (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92: 151-159.
3. Lambert R, Hainaut P, (2007) The multidisciplinary management of gastrointestinal cancer Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 21: 921-945.
4. Law FB, Chen YW, Wong KY, Ying J, Tao Q, et al. (2007) Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma. Oncogene 26: 7490-7498.
5. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, et al. (2006) Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699.
6. Wang XX, Liu R, Jin SQ, Fan FY, Zhan QM, (2006) Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Res 16: 356-366.
7. Arai H, Ueno T, Tangoku A, Yoshino S, Abe T, et al. (2003) Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet 146: 16-21.
8. Miller CT, Aggarwal S, Lin TK, Dagenais SL, Contreras JI, et al. (2003) Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. Cancer Res 63: 4136-4143.
9. Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, et al. (2002) MYEOV, a gene at 11q13 is coamplified with CCND1 but epigenetically inactivated in a subset of esophageal squamous cell carcinomas. J Hum Gene 47: 460-464.
10. Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, et al. (2002) Identification of a novel gene GASC1 within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 60: 4735-4739.
11. Chiang PW, Beer DG, Wei WL, Orringer MB, Kurnit DM, et al. (1999) Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients. Clin Cancer Res 5: 1381-1386.
12. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, et al. (1992) Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980-2983.
13. Carneiro A, Isinger A, Karlsson A, Johansson J, Jonsson G, et al. (2008) Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer. BMC Cancer 8: 98-104.
14. Shi ZZ, Liang JW, Zhan T, Wang BS, Lin DC, et al. (2011) Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization. Genes Chromosomes Cancer 50: 518-526.
15. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S,et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Gene 41: 1238-1242.
16. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuris S, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
17. Brown J, Bothma H, Veale R, Willem P, (2011) Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes. World J Gastroenterol 17: 2909-2923.
18. Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL, (2004) SeeGH-a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 5: 13-13.
19. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
20. Holmes RS, Vaughan TL, (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17: 2-9.
21. Thompson SK, Ruszkiewicz AR, Jamieson GG, Esterman A, Watson DI, et al. (2008) Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol 15: 3447-3458.
22. Allen JW, Richardson JD, Edwards MJ, (1997) Squamous cell carcinoma of the esophagus: a review and update. Surg Oncol 6: 193-200.
23. Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, et al. (2011) Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell 19: 347-358.
24. Nagasawa S, Onda M, Sasajima K, Makino H, Yamashita K, et al. (2001) Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma. J Surg Oncol 78: 208-214.
25. Kunisaki C, Shimada H, Akiyama H, Nomura M, Matsuda G, et al. (2004) Prognostic factors in esophageal cancer. Hepatogastroenterology 51: 736-740.
26. Liu GY, Luo Q, Xiong B, Pan C, Yin P, et al. (2008) Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors. World J Gastroenterol 14: 7199-7207.
27. Lin DC, Du XL, Wang MR, (2009) Protein alterations in ESCC and clinical implications:a review. Dis Esophagus 22: 9-20.
28. Peng H, Zhong XY, Liu KP, Li SM, (2009) Expression and significance of adenomatous polyposis coli beta-catenin E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray. Ai Zheng 28: 38-41.
29. Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, et al. (1998) Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene 17: 2313-2322.
30. Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, et al. (1999) Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 5: 2133-2139.
31. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, et al. (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133.
32. Rodrigo JP, Garcia-Carracedo D, Garcia LA, Menendez S, Allonca E, et al. (2009) Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 217: 516-523.
33. Luo ML, Wang MR, (2007) CTTN (EMS1): an oncogene contributing to the metastasis of esophageal squamous cell carcinoma. Cell Res 17: 298-300.
34. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi G, et al. (2004) Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 41: 629-636.
35. Zheng M, Simon R, Mirlacher M, Maurer R, Gasser T, et al. (2004) TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol 165: 63-69.
36. Nandan MO, McConnell BB, Ghaleb AM, Patel NV, Robine S, et al. (2008) Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 134: 120-130.
37. Ying J, Li H, Cui Y, Wong AH, Langford C, et al. (2006) Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia 20: 1173-1175.
38. Sun X, Frierson HF, Chen C, Li C, Ran Q, et al. (2005) Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 37: 407-412.
39. Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, et al. (2008) DCC promoter hypermethylation in esophageal squamous cell carcinoma. Int J Cancer 122: 2498-2502.
40. Chattopadhyay I, Singh A, Phukan R, Paukayastha J, Kataki A, et al. (2010) Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat Res 696: 130-138.
41. Maesawa C, Tamura G, Nishizuka S, Iwaya T, Ogasawara S, et al. (1997) MAD-related genes on 18q21.1, Smad2 and Smad4, are altered infrequently in esophageal squamous cell carcinoma. Jpn J Cancer Res 88: 340-343.
42. Zen K, Yasui K, Gen Y, Dohi O, Wakabayashi N, et al. (2009) Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma. Oncogene 28: 2910-2918.
43. Ying J, Li H, Seng TJ, Langford C, Srivastava G, et al. (2006) Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal esophageal and multiple other carcinomas with frequent methylation. Oncogene 25: 1070-1080.
44. Hurst CD, Fiegler H, Carr P, Wiiliams S, Carter NP, et al. (2004) High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23: 2250-2263.
45. Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, et al. (2003) DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36: 361-374.